Alogliptin Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 6.25 mg, 12.5 mg, 25 mg
Reference Brands: Nesina (USA/EU), Kazano (USA), Vipidia (EU)
Category:
Diabetes
Alogliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor used to manage type 2 diabetes mellitus. It helps lower blood glucose levels by increasing insulin secretion and decreasing glucagon release in response to meals. Alogliptin is available as oral tablets, either as monotherapy or in combination with metformin or pioglitazone, to improve glycemic control.
Alogliptin Tablet is available in Tablet
and strengths such as 6.25 mg, 12.5 mg, 25 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Alogliptin Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Alogliptin Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Alogliptin tablets are oral antidiabetic medications used for the management of type 2 diabetes mellitus, particularly in patients who are unable to achieve adequate glycemic control through diet and exercise alone. The active ingredient, alogliptin benzoate, belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by increasing the levels of incretin hormones such as GLP-1 and GIP, which play a key role in regulating blood glucose levels. These hormones stimulate insulin release from the pancreas in response to meals and reduce the amount of glucose produced by the liver. As a result, alogliptin helps lower both fasting and postprandial blood sugar levels without causing significant hypoglycemia when used alone. The medication is generally well tolerated and is often prescribed either as monotherapy or in combination with other antidiabetic agents. Its once-daily dosing improves patient compliance, making it a convenient and effective option for long-term diabetes management.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing